L. Wickerham

发表

Tamoxifen – An Update on Current Data and Where it Can Now be Used

L. Wickerham, 2002, Breast Cancer Research and Treatment.

The efficacy of bone scanning in the follow-up of patients with operable breast cancer

R. Foster, A. Glass, B. Fisher, 2005, Breast Cancer Research and Treatment.

How conversations about adjuvant hormonal therapy differ from 'typical' oncology discussions: Results of an observational linguistic study.

V. Vogel, B. Davidson, L. Wickerham, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)

P. Fasching, C. Perou, J. Bergh, 2012 .

Pathologic findings from the national surgical adjuvant breast project (protocol 6). Relation of local breast recurrence to multicentricity

B. Fisher, E. Fisher, R. Sass, 1986, Cancer.

Differing Perspectives on Breast Cancer Chemoprevention.

J. Cuzick, T. Powles, L. Wickerham, 2016, JAMA oncology.

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

T. Walsh, M. King, L. Ford, 2001, JAMA.

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.

B Fisher, C. Redmond, N. Wolmark, 1989, The New England journal of medicine.

Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

C. Redmond, N. Wolmark, A. Glass, 1989 .

SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1

J. Cairns, R. Weinshilboum, Liewei Wang, 2017, PLoS genetics.

Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS)

S. Paik, B. Fisher, B. Fisher, 1986, Cancer.

Pathologic findings from the national surgical adjuvant breast project (protocol no. 4): XI. Bilateral breast cancer

B. Fisher, E. Fisher, R. Sass, 1984, Cancer.

Abstract S1-11: Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)

P. Fasching, C. Perou, J. Bergh, 2012 .

Long-term tamoxifen citrate use and potential ocular toxicity.

C. Redmond, J. Costantino, N. Wolmark, 1998, American journal of ophthalmology.

Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.

V. Vogel, B. Davidson, L. Wickerham, 2007, The journal of supportive oncology.

Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS)

S. Paik, B. Fisher, E. Fisher, 1986 .

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

B Fisher, C. Redmond, N. Wolmark, 1985, The New England journal of medicine.

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Gideon Blumenthal, Nina Ditsch, David Cameron, 2014, The Lancet.

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum

H. Rockette, N. Petrelli, H. Wieand, 1997, Diseases of the colon and rectum.

Estimated risk of invasive breast cancer in postmenopausal women with and without family history of the disease

B. Mitchell, D. Muram, L. Wickerham, 2011, Menopause.